{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:22:22Z","timestamp":1772119342501,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-03042-9","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T03:02:15Z","timestamp":1691982135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring safety and efficacy of rivaroxaban after living donor liver transplantation: a retrospective study"],"prefix":"10.1007","volume":"408","author":[{"given":"Bilal Ahmed","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubair","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Ihsan-ul-Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Yasir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohail","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammara","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal Saud","family":"Dar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"3042_CR1","doi-asserted-by":"publisher","unstructured":"Salerno DM, Tsapepas D, Papachristos A et al (2017) Direct oral anticoagulant considerations in solid organ transplantation: a review. Clin Transplant 31. https:\/\/doi.org\/10.1111\/ctr.12873","DOI":"10.1111\/ctr.12873"},{"key":"3042_CR2","doi-asserted-by":"publisher","first-page":"8004","DOI":"10.3748\/wjg.v21.i26.8004","volume":"21","author":"P Feltracco","year":"2015","unstructured":"Feltracco P, Barbieri S, Cillo U et al (2015) Perioperative thrombotic complications in liver transplantation. World J Gastroenterol 21:8004\u20138013. https:\/\/doi.org\/10.3748\/wjg.v21.i26.8004","journal-title":"World J Gastroenterol"},{"key":"3042_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/08998280.2001.11927781","volume":"14","author":"M Kuruvilla","year":"2001","unstructured":"Kuruvilla M, Gurk-Turner C (2001) A review of warfarin dosing and monitoring. Proc Bayl Univ Med Cent 14:305\u2013306","journal-title":"Proc Bayl Univ Med Cent"},{"key":"3042_CR4","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1111\/bcp.14833","volume":"87","author":"M Wang","year":"2021","unstructured":"Wang M, Zeraatkar D, Obeda M et al (2021) Drug-drug interactions with warfarin: a systematic review and meta-analysis. Br J Clin Pharmacol 87:4051\u20134100. https:\/\/doi.org\/10.1111\/bcp.14833","journal-title":"Br J Clin Pharmacol"},{"key":"3042_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1055\/s-0040-1710592","volume":"120","author":"L Villa Zapata","year":"2020","unstructured":"Villa Zapata L, Hansten PD, Panic J et al (2020) Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis. Thromb Haemost 120:1066\u20131074. https:\/\/doi.org\/10.1055\/s-0040-1710592","journal-title":"Thromb Haemost"},{"key":"3042_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines9050445","volume":"9","author":"C Dunois","year":"2021","unstructured":"Dunois C (2021) Laboratory monitoring of direct oral anticoagulants (DOACs). Biomedicines 9:445. https:\/\/doi.org\/10.3390\/biomedicines9050445","journal-title":"Biomedicines"},{"key":"3042_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.beha.2013.07.009","volume":"26","author":"R Shameem","year":"2013","unstructured":"Shameem R, Ansell J (2013) Disadvantages of VKA and requirements for novel anticoagulants. Best Pract Res Clin Haematol 26:103\u2013114. https:\/\/doi.org\/10.1016\/j.beha.2013.07.009","journal-title":"Best Pract Res Clin Haematol"},{"key":"3042_CR8","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1097\/TP.0000000000004195","volume":"106","author":"J Rimsans","year":"2022","unstructured":"Rimsans J, Sylvester K, Kim M et al (2022) A review of direct-acting oral anticoagulants and their use in solid organ transplantation. Transplantation 106:2143\u20132154. https:\/\/doi.org\/10.1097\/TP.0000000000004195","journal-title":"Transplantation"},{"key":"3042_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1177\/1526924816661951","volume":"26","author":"AB Lichvar","year":"2016","unstructured":"Lichvar AB, Moore CA, Ensor CR et al (2016) Evaluation of direct oral anticoagulation therapy in heart and lung transplant recipients. Prog Transplant Aliso Viejo Calif 26:263\u2013269. https:\/\/doi.org\/10.1177\/1526924816661951","journal-title":"Prog Transplant Aliso Viejo Calif"},{"key":"3042_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/tri.13804","volume":"34","author":"C Pfrepper","year":"2021","unstructured":"Pfrepper C, Herber A, Weimann A et al (2021) Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation. Transpl Int Off J Eur Soc Organ Transplant 34:423\u2013435. https:\/\/doi.org\/10.1111\/tri.13804","journal-title":"Transpl Int Off J Eur Soc Organ Transplant"},{"key":"3042_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.thromres.2014.06.020","volume":"134","author":"A G\u00f3mez-Outes","year":"2014","unstructured":"G\u00f3mez-Outes A, Terleira-Fern\u00e1ndez AI, Lecumberri R et al (2014) Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis. Thromb Res 134:774\u2013782. https:\/\/doi.org\/10.1016\/j.thromres.2014.06.020","journal-title":"Thromb Res"},{"key":"3042_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet Lond Engl 383:955\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet Lond Engl"},{"key":"3042_CR13","doi-asserted-by":"publisher","first-page":"e204095","DOI":"10.1001\/jamasurg.2020.4095","volume":"155","author":"AW Avolio","year":"2020","unstructured":"Avolio AW, Franco A, Schlegel A et al (2020) Development and validation of a comprehensive model to estimate early allograft failure among patients requiring early liver retransplant. JAMA Surg 155:e204095. https:\/\/doi.org\/10.1001\/jamasurg.2020.4095","journal-title":"JAMA Surg"},{"key":"3042_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jhep.2020.12.009","volume":"75","author":"AW Avolio","year":"2021","unstructured":"Avolio AW, Lai Q, Cillo U et al (2021) L-GrAFT and EASE scores in liver transplantation: need for reciprocal external validation and comparison with other scores. J Hepatol 75:729\u2013731. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.009","journal-title":"J Hepatol"},{"key":"3042_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","volume":"128","author":"GD Barnes","year":"2015","unstructured":"Barnes GD, Lucas E, Alexander GC, Goldberger ZD (2015) National trends in ambulatory oral anticoagulant use. Am J Med 128:1300\u20131305.e2. https:\/\/doi.org\/10.1016\/j.amjmed.2015.05.044","journal-title":"Am J Med"},{"key":"3042_CR16","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1097\/TP.0000000000000223","volume":"98","author":"A Wannhoff","year":"2014","unstructured":"Wannhoff A, Weiss KH, Schemmer P et al (2014) Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. Transplantation 98:e12\u2013e13. https:\/\/doi.org\/10.1097\/TP.0000000000000223","journal-title":"Transplantation"},{"key":"3042_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/0091270005276202","volume":"45","author":"S Liu","year":"2005","unstructured":"Liu S, Frye RF, Branch RA et al (2005) Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation. J Clin Pharmacol 45:666\u2013673. https:\/\/doi.org\/10.1177\/0091270005276202","journal-title":"J Clin Pharmacol"},{"key":"3042_CR18","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/lt.22381","volume":"17","author":"SF Wang","year":"2011","unstructured":"Wang SF, Huang ZY, Chen XP (2011) Biliary complications after living donor liver transplantation. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 17:1127\u20131136. https:\/\/doi.org\/10.1002\/lt.22381","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"3042_CR19","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1016\/j.jacc.2019.04.052","volume":"73","author":"S-R Lee","year":"2019","unstructured":"Lee S-R, Lee H-J, Choi E-K et al (2019) Direct oral anticoagulants in patients with atrial fibrillation and liver disease. J Am Coll Cardiol 73:3295\u20133308. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.052","journal-title":"J Am Coll Cardiol"},{"key":"3042_CR20","doi-asserted-by":"publisher","first-page":"e13756","DOI":"10.1111\/ctr.13756","volume":"34","author":"AD Santeusanio","year":"2020","unstructured":"Santeusanio AD, Weinberg AD, Florman SS, Schiano TD (2020) Safety of direct-acting oral anticoagulants relative to warfarin in a matched cohort of liver transplant recipients. Clin Transplant 34:e13756. https:\/\/doi.org\/10.1111\/ctr.13756","journal-title":"Clin Transplant"},{"key":"3042_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5500\/wjt.v6.i1.220","volume":"6","author":"P Wiesen","year":"2016","unstructured":"Wiesen P, Massion PB, Joris J et al (2016) Incidence and risk factors for early renal dysfunction after liver transplantation. World J Transplant 6:220\u2013232. https:\/\/doi.org\/10.5500\/wjt.v6.i1.220","journal-title":"World J Transplant"},{"key":"3042_CR22","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/lt.23522","volume":"18","author":"ML Weber","year":"2012","unstructured":"Weber ML, Ibrahim HN, Lake JR (2012) Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 18:1290\u20131301. https:\/\/doi.org\/10.1002\/lt.23522","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"3042_CR23","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","volume":"76","author":"GF Tomaselli","year":"2020","unstructured":"Tomaselli GF, Mahaffey KW, Cuker A et al (2020) 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 76:594\u2013622. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.053","journal-title":"J Am Coll Cardiol"},{"key":"3042_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000446848","volume":"44","author":"RS Kalil","year":"2016","unstructured":"Kalil RS, Kaboli PJ, Liu X, Vaughan-Sarrazin M (2016) Association between renal function and bleeding risk for dabigatran after switching from warfarin. Am J Nephrol 44:11\u201318. https:\/\/doi.org\/10.1159\/000446848","journal-title":"Am J Nephrol"},{"key":"3042_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/ejh.12610","volume":"95","author":"A G\u00f3mez-Outes","year":"2015","unstructured":"G\u00f3mez-Outes A, Su\u00e1rez-Gea ML, Lecumberri R et al (2015) Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives. Eur J Haematol 95:389\u2013404. https:\/\/doi.org\/10.1111\/ejh.12610","journal-title":"Eur J Haematol"},{"key":"3042_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/phar.2485","volume":"41","author":"AL Bixby","year":"2021","unstructured":"Bixby AL, Lichvar AB, Salerno D, Park JM (2021) Use of direct-acting oral anticoagulants in solid organ transplantation: a systematic review. Pharmacotherapy 41:28\u201343. https:\/\/doi.org\/10.1002\/phar.2485","journal-title":"Pharmacotherapy"},{"key":"3042_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/11317550-000000000-00000","volume":"49","author":"CE Staatz","year":"2010","unstructured":"Staatz CE, Goodman LK, Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part II. Clin Pharmacokinet 49:207\u2013221. https:\/\/doi.org\/10.2165\/11317550-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"3042_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1502000","volume":"373","author":"CV Pollack","year":"2015","unstructured":"Pollack CV, Reilly PA, Eikelboom J et al (2015) Idarucizumab for dabigatran reversal. N Engl J Med 373:511\u2013520. https:\/\/doi.org\/10.1056\/NEJMoa1502000","journal-title":"N Engl J Med"},{"key":"3042_CR29","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40271-013-0020-5","volume":"6","author":"F Lalibert\u00e9","year":"2013","unstructured":"Lalibert\u00e9 F, Bookhart BK, Nelson WW et al (2013) Impact of once-daily versus twice-daily dosing frequency on adherence to chronic medications among patients with venous thromboembolism. Patient 6:213\u2013224. https:\/\/doi.org\/10.1007\/s40271-013-0020-5","journal-title":"Patient"},{"key":"3042_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/VHRM.S55246","volume":"10","author":"S Haas","year":"2014","unstructured":"Haas S, Bode C, Norrving B, Turpie AG (2014) Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk. Vasc Health Risk Manag 10:101\u2013114. https:\/\/doi.org\/10.2147\/VHRM.S55246","journal-title":"Vasc Health Risk Manag"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03042-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03042-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:11:29Z","timestamp":1705576289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03042-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3042"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03042-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2966403\/v1","asserted-by":"object"}]},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board at Pakistan Kidney and Liver Institute & Research Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"308"}}